A detailed history of Pnc Financial Services Group, Inc. transactions in Merus N.V. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 4,300 shares of MRUS stock, worth $213,537. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,300
Holding current value
$213,537
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$47.19 - $58.84 $202,917 - $253,012
4,300 New
4,300 $214,000
Q2 2022

Aug 12, 2022

BUY
$13.98 - $29.25 $1,398 - $2,925
100 New
100 $2,000

Others Institutions Holding MRUS

About Merus N.V.


  • Ticker MRUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,878,200
  • Market Cap $2.28B
  • Description
  • Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...
More about MRUS
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.